Table 7.
Characteristics CTCL stage, n (%) | Vorinostat (n = 74) |
---|---|
IB | (14.9%) |
IIA | 2 (2.7%) |
IIB | 19 (25.7%) |
III | 22 (29.7%) |
IVA | 16 (21.6%) |
IVB | 4 (5.4%) |
Clinical Characteristics | |
Number of prior systemic treatments, median (range) | 3.0 (1.0, 12.0) |